Pig Pancreas Cells Seem to Thrive in Diabetic Monkeys


By: dhtest

Awhile back, three macaque monkeys with type 1 diabetes received transplants of 19 pig pancreas primordia, each one smaller than the period at the end of this sentence.

Primordia are embryonic cells. Unlike stem cells, however, which can become any type of cell, primordia are destined to become pancreatic cells.

Because they are embryonic, primordia do not elicit the immune response triggered by more mature pancreatic cells. As a result, the monkeys did not require any immunosuppressive drugs. Within several weeks of the transplants, the cells became established, matured and began producing pig insulin.

It’s been two years now for one of the monkeys, and the pig insulin it produces has reduced its need for injected insulin by 50 percent. A second monkey is 10 months post-transplant, and its need for injected insulin continues to decline. The third monkey, sadly, died of unrelated reasons.

The researchers believe that additional transplants should entirely eliminate the monkeys’ need for injected insulin. They hope eventually to conduct clinical trials in humans using the same technique.

* * *

Source: Washington University in St. Louis Record, November 2007



Diabetes Health Medical Disclaimer
The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.